US Stocks
/
Dyne Therapeutics, Inc. Share Price
Dyne Therapeutics, Inc. Share Price

Dyne Therapeutics, Inc. Share Price

NASDAQ: DYN | Mid Cap
$17.11
-$0.93 (-5.16%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Dyne Therapeutics, Inc. Stock Performance

Open
$18.03
Prev. Close
$18.04
Circuit Range
N/A
Day Range
$16.98 - $18.03
Year Range
$11.92 - $27.22
Volume
1,63,840
Average Traded
$17.17

Dyne Therapeutics, Inc. Share Price Today

As of 20 September 2026, Dyne Therapeutics, Inc.'s share price is $17.11. The stock opened at $18.03, compared to its previous close of $18.04. During today's trading session, Dyne Therapeutics, Inc.'s share price traded between $16.98 and $18.03, with an average price of $17.51. Over the past 52 weeks, the stock has recorded a high of $27.22 and a low of $11.92. In terms of performance, Dyne Therapeutics, Inc.'s share price has declined by 5.57% over the last six months and is up 35.36% on a year-on-year basis.

Dyne Therapeutics, Inc. Share Price Chart

$16.98$18.03
L
Show Current Price
H

Dyne Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.20B
PE Ratio (TTM)
-4.93
Dividend Yield
N/A
EPS (TTM)
$-3.47
Revenue (TTM)
N/A
Return On Equity (TTM)
-45.90%
Profit Margin
N/A
Debt to Equity
0.05
Quarterly Earnings Growth YoY
-11.24%

Dyne Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$65.65M-$65.10M-$97.13M-$115.36M-$110.86M-$108.04M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A0.83%-49.19%-18.78%3.90%2.54%

Dyne Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$149.29M-$168.10M-$235.94M-$317.42M-$446.21M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-12.60%-40.36%-34.54%-40.58%

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$25.18
$17.10
-34.46%
Aug 2026
$24.59
$26.09
+3.63%
Jul 2026
$22.37
$25.18
+13.35%
Jun 2026
$18.80
$22.21
+14.90%
May 2026
$17.38
$19.33
+10.14%
Apr 2026
$18.76
$17.55
-3.15%
Mar 2026
$14.77
$18.12
+15.93%
Feb 2026
$17.93
$15.63
-12.73%
Jan 2026
$19.59
$17.91
-8.41%
Dec 2025
$21.38
$19.55
-10.79%
Nov 2025
$22.32
$21.92
-2.97%
Oct 2025
$12.74
$22.59
+78.72%

DYN Share Price FAQs

What is Dyne Therapeutics, Inc. share price today?

chevron-up
Dyne Therapeutics, Inc. share price today is $17.11 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Dyne Therapeutics, Inc. stock?

chevron-up
The 52 week high of Dyne Therapeutics, Inc. stock is $27.22, while the 52 week low is $11.92 as of 19 Sep '26.

What is DYN's market capitalisation today?

chevron-up
DYN market capitalisation is $2.20B as of September 20, 2026, at 4:36 pm IST.

What is DYN's net income for the last quarter?

chevron-up
DYN's net income for the last quarter is -0.11B USD.

What is the 5 year returns of DYN?

chevron-up
The 5 year returns of DYN is 5.36% as on 19 Sep '26.

What is the high & low stock price of DYN today?

chevron-up
DYN stock price hit a high of $18.03 and low of $16.98 as of 19 Sep '26.

Can I buy DYN shares in India?

chevron-up
Yes. You can buy DYN in India by opening an international trading account.